Title of the publication | Control of Fluoroquinolone Resistance through Successful Regulation, Australia |
---|---|
Abstract | Fluoroquinolone antimicrobial drugs are highly bioavailable, broad-spectrum agents with activity against gram-negative pathogens, especially those resistant to other classes of antimicrobial drugs. Australia has restricted the use of quinolones in humans through its national pharmaceutical subsidy scheme; and, through regulation, has not permitted the use of quinolones in food-producing animals. As a consequence, resistance to fl uoroquinolones in the community has been slow to emerge and has remained at low levels in key pathogens, such as Escherichia coli. In contrast to policies in most other countries, this policy has |
DOI | http://dx.doi.org/10.3201/eid1809.111515 |
Name of the first author | Cheng, Allen |
Year of publication | 2012 |
Study design of the publication | Other study design |
If other study design, please specify | policy review |
Method for data collection and analysis |
|
Mixed | |
Sector |
|
Sub-sector | Sub-sectors are further units of demarcation within a sector E.g. awareness campaign from veterinarians to cat owners about toxoplasmosis drug resistance and transmission of resistant bacteria: ANIMAL, PETS |
Subsector (human) |
|
General (human health) | |
Subsector (animal) |
|
admin2024-03-04T19:29:30+00:00